HOME >> BIOLOGY >> NEWS
Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax

Anthrax vaccine administered in combination with a short course of antibiotics completely protected nonhuman primates from inhalational anthrax, the most lethal form of the disease, according to scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

In a collaborative study involving USAMRIID and the National Institute of Allergy and Infectious Diseases (NIAID), investigators demonstrated that postexposure vaccination can shorten the duration of antibiotic treatment required to protect against inhalational anthrax. The findings, which appear in this week's online edition of Proceedings of the National Academy of Sciences, could have important implications for public health management of anthrax bioterrorism events.

Anthrax is caused by the spore-forming bacterium Bacillus anthracis, and causes three types of disease--cutaneous, gastrointestinal, and inhalational--depending upon the route of exposure. Inhalational anthrax--the type likely to occur following a bioterrorist attack--is difficult to diagnose early, and despite antibiotic therapy, has a high fatality rate. In addition, because anthrax spores can remain in the body for extended periods, antibiotic treatment is typically recommended for 60 days or more following exposure.

As noted by the authors, following the 2001 anthrax attacks in the United States, approximately 10,000 people were offered 60 days of antibiotic therapy to prevent inhalational anthrax. Adverse events associated with this regimen--including diarrhea, nausea, vomiting, and dizziness--were commonly reported. More importantly, only about 44 percent of people completed the whole 60-day course. Thus, minimizing the duration of postexposure antibiotic treatment could be crucial to a successful defense against a large-scale anthrax attack.

In the study, two groups of rhesus macaques were exposed to very high amounts of anthrax spores by aerosol. Both groups were then given c
'"/>

Contact: Caree Vander Linden
Caree.Vanderlinden@us.army.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases
1-May-2006


Page: 1 2 3

Related biology news :

1. Vaccine trials inject hope into koalas future
2. Vaccine hope for malaria
3. Vaccine prevents prion disease in mice
4. Vaccine hope for sufferers of potentially fatal stomach bug
5. Vaccine to cope with viral diversity in HIV
6. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
7. U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication
8. Vaccine-producing plant-factories
9. HPV Vaccine: Whats next
10. Vaccine shown effective against chancroid
11. Vaccine provides 100 percent protection against avian flu virus in animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 09, 2019 , ... Dr. Beanlands is the Vered ... Ottawa, Ontario, Canada. He is also Director of its National Cardiac PET Centre, ... the Department of Radiology, and in the Department of Cellular and Molecular medicine. , ...
(Date:1/10/2019)... ... January 10, 2019 , ... A major goal ... in vitro studies and significantly more expensive in vivo studies in order to ... To address this need, researchers have begun to adopt 3D cell culture models ...
(Date:1/8/2019)... ... January 07, 2019 , ... PureWay, a healthcare-focused provider ... Thomas Kennedy as head of sales and business development efforts, effective immediately. Mr. ... has previously worked for Johnson & Johnson Medical, Globus Medical, WRP Asia Pacific, ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... POWAY, Calif. (PRWEB) , ... January 22, 2019 , ... ... been using the Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly ... perform VetStem Regenerative Cell Therapy since 2007 and began using V-PET™ 2016. ...
(Date:1/20/2019)... ... ... On January 15 of this year, the Parents’ Guide to Cord Blood website ... M.D., Ph.D. The PGCB was founded by former physicist Dr. Frances Verter, who ... 21st year of operation, the PGCB continues its mission to educate parents with accurate ...
(Date:1/20/2019)... (PRWEB) , ... January 17, 2019 , ... ... and orchestration system software developer, and The Quick Life Science Group (Quick Healthcare ... platform. , The platform enables the global cell and gene therapy industry to ...
(Date:1/11/2019)... ... January 11, 2019 , ... Drawing on over 22 years ... 22, 2019 at 2:30pm EST will explore some of the key lessons that have ... one vendor vs. using multiple vendors, and find out how to ensure that you ...
Breaking Biology Technology:
Cached News: